Clinical Trials in Nashville

Showing 4421-4440 of 20,298 trials

Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus

NCT02052739

The purpose of this study is to evaluate the safety and tolerability of SAGE-547 in participants in super-refractory status epilepticus (SRSE).

Super-refractory Status Epilepticus

Supernus Pharmaceuticals, Inc.25 participantsStarted Mar 2014

Birmingham, Alabama, United States • Sarasota, Florida, United States • Chicago, Illinois, United States +14 more locations

Active Not RecruitingNA< 1 mile

Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.

NCT05024695

Evaluate the safety and effectiveness of iSTAR Medical's MINIject™ implant for lowering intraocular pressure (IOP) in subjects with primary open-angle glaucoma.

Glaucoma

iSTAR Medical975 participantsStarted Aug 2021

Glendale, Arizona, United States • Fayetteville, Arkansas, United States • Beverly Hills, California, United States +34 more locations

Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus

Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.

Find Trials by Condition in Nashville

Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors

Co-Use of Opioid Medications and Alcohol Prevention Study

Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages

Periprosthetic Fracture Registry (PPFx)

NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922)

DFC 004 Biomarkers for Active Diabetic Foot Ulcers

A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer

Clinical Utility of Residual Hearing in the Cochlear Implant Ear

A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy

A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors

A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity

A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease Mild Cognitive Impairment (PD-MCI)

First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

PROmotion of COVID-19 BOOSTer VA(X)Ccination in the Emergency Department - PROBOOSTVAXED

Pharmacodynamic EffIcacy and Clinical Benefit of AT 007 in Patients With Sorbitol Dehydrogenase (SORD) Deficiency

Use of Stromal Vascular Fraction in Multiple Sclerosis

Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders